Protecting Clients Coast to Coast

For 30 years, Faruqi & Faruqi has been dedicated to protecting the rights of shareholders, employees, and consumers through integrity, respect, and results. 

Who We Are

Over 30 Years Of Working Experience In Legal Solutions

Faruqi & Faruqi, LLP’s national practice focuses on complex civil litigation. The firm practices in the areas of Securities, Merger & Transactional, Shareholder Derivative, Antitrust, Consumer Class Action and Wage & Hour litigation.

Take Action

View our active case list and determine whether you want to participate in an action with us now
View All
Inform us of any fraud or unfair business practice using the link below
Report a Fraud
A class action suit can provide merger scrutiny to ensure you are protected
Merger Information
What we do

Client Services

Faruqi & Faruqi strives to provide exceptional client services. These services include:
Portfolio Monitoring
We review the investment portfolios of institutional clients and prepare detailed reports.
Learn More
Corporate Governance and Regulatory Compliance
We monitor changes in the law to protect shareholders from corporate non-compliance.
Learn More
Case Evaluation
We perform complex damage analyses to evaluate the merit of clients’ cases.
Learn More
Practice Areas

Our Legal Work

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia, and Pennsylvania.

Are You an Affected Shareholder?

Faruqi & Faruqi, LLP is actively investigating the following cases:
15 Sep 2025
V.F. Corporation
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In VFC To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in VFC between October 30, 2023 and May 20, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) and reminds investors of the November 12, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: the true state of VFC’s turnaround plans; notably, that additional significant reset actions would be necessary to return the Vans brand to growth, resulting in significant setbacks to Vans’ revenue growth trajectory. These statements caused Plaintiff and other shareholders to purchase and/or acquire VFC’s securities at artificially inflated prices. The truth emerged on May 21, 2025, when VFC reported its fourth quarter and full-year fiscal 2025 results, highlighting a significant decline in Vans’ growth trajectory, which faltered from an 8% loss the quarter before to a 20% loss in the fourth quarter, and noting such decline would continue through the next quarter. The Company attributed its results and below-expectation guidance largely as “a direct effect of deliberately reduced revenue to eliminate unprofitable or unproductive businesses” and “an additional set of deliberate actions” already in-place but previously unannounced. VFC further noted that, disregarding these deliberate actions, Vans would still have shown a “high single digit[]” revenue decline, suggesting growth slowed in comparison to the prior years’ sequential improvements irrespective of management’s new “deliberate actions.” Investors and analysts reacted immediately to VFC’s revelation. The price of VFC’s common stock declined dramatically. From a closing market price of $14.43 per share on May 20, 2025, VFC’s stock price fell to $12.15 per share on May 21, 2025, a decline of about 15.8% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding VFC’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the V.F. Corporation class action, go to www.faruqilaw.com/VFC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
55 Days
Take Action
12 Sep 2025
Lantheus Holdings, Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lantheus To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. According to the complaint, defendants provided investors with misleading statements concerning the true state of Pylarify’s competitive position; notably, that Lantheus was not equipped to properly assess the pricing and competitive dynamics for Pylarify, risking Pylarify’s price point, revenue, and overall growth potential. These statements caused Plaintiff and other shareholders to purchase Lantheus’ securities at artificially inflated prices. Investors began to question the veracity of Defendants’ public statements on May 7, 2025, when Lantheus reported its first quarter results below market expectations with Pylarify’s performance particularly falling short. Then, on August 6, 2025, Lantheus again announced disappointing results and significantly reduced growth expectations for Pylarify, which had fallen 8.3% year-over-year, and slashed fiscal year 2025 growth projections. Defendants attributed the losses to the ongoing competition, impacting Pylarify’s pricing dynamics. Investors and analysts reacted promptly to Lantheus’ revelations. The price of Lantheus’ common stock declined dramatically. From a closing market price of $72.83 per share on August 5, 2025, Lantheus’ stock price fell to $51.87 per share on August 6, 2025, a decline of about 28.8% in the span of one day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Lantheus’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Lantheus Holdings, Inc. class action, go to www.faruqilaw.com/LNTH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.      
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
53 Days
Take Action
8 Sep 2025
Savara Inc.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Savara To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) and reminds investors of the November 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the MOLBREEVI BLA lacked sufficient information regarding MOLBREEVI’s chemistry, manufacturing, and/or controls; (2) accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form; (3) the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors; (iv) the delay in MOLBREEVI’s regulatory approval increased the likelihood that the Company would need to raise additional capital; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times. On May 27, 2025, Savara issued a press release “announc[ing] that the Company received [a refusal to file] letter from the FDA for the [Biologics License Application] of MOLBREEVI as a therapy to treat patients with autoimmune PAP.” On this news, Savara’s stock price fell $0.90 per share, or 31.69%, to close at $1.94 per share on May 27, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Savara’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Savara class action, go to www.faruqilaw.com/SVRA or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.    
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
50 Days
Take Action
5 Sep 2025
Quantum Corporation
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Quantum Corporation To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Quantum Corporation between November 15, 2024 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quantum Corporation (“Quantum Corporation” or the “Company”) (NASDAQ: QMCO) and reminds investors of the November 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Quantum Corporation improperly recognized revenue during the fiscal year ended March 31, 2025; (2) Quantum Corporation would therefore need to restate its previously filed financial statements for the fiscal third quarter ended December 31, 2024; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. On June 30, 2025, Quantum disclosed that it would be unable to timely file its annual financial report for the fiscal year 2025 as it is “reviewing its accounting related to certain revenue contracts as well as the application of standalone selling price under applicable accounting standards.” On this news, Quantum’s stock price fell $1.00, or 10.03%, to close at $8.97 per share on June 30, 2025, thereby injuring investors. Then, on August 8, 2025, Quantum announced that its third quarter 2024 financial statements “should no longer be relied upon” due to “deficiencies in the Company’s internal control over financial reporting and the Company’s disclosure controls and procedures that constituted material weaknesses.” The Company further disclosed that the affected financial statements would be restated to show a new decrease of approximately $3.9 million in revenue. On this news, Quantum’s stock price fell $0.14, or 1.79%, to close at $7.66 per share on August 11, 2025. Then, on August 18, 2025, Quantum disclosed that its CEO would be resigning from the role after only five months in the position. On this news, Quantum’s stock price fell $0.61, or 8.2%, to close at $6.83 per share on August 19, 2025, thereby injuring investors further. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Quantum Corporation’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Quantum Corporation class action, go to www.faruqilaw.com/QMCO or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
James M. Wilson, Jr.
Robert W. Killorin
Lead Plaintiff Deadline
46 Days
Take Action
Testimonials

Court Praises

Updates from Us

Latest News

See All
12 Sep 2025
Faruqi & Faruqi Beats Motion to Dismiss in Luminar Technologies Securities Litigation and Advances the Case to Discovery
Read More
4 Sep 2025
Faruqi & Faruqi Beats Motion to Dismiss in Sun-Maid Litigation
Read More
7 Apr 2025
Faruqi & Faruqi, LLP has been ranked in Chambers and Partner’s New York Chambers Spotlight 2025 Guide and recognized as a leader in the employment litigation industry
Read More

From the Blog

See All
8 Sep 2025
FDIC Opens Door for Banks to Enter Digital Asset Market
Read More
8 Sep 2025
Arbitration Agreements Require Basic Fairness—Or They Won’t Be Enforced
Read More
8 Sep 2025
Court Approves $2.8 billion BCBS Antitrust Settlement
Read More

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771